Aadi Bioscience, Inc. reported earnings results for the fourth quarter ended December 31, 2021. For the fourth quarter, the company reported revenue was USD 1 million compared to USD 14.15 million a year ago. Net loss was USD 15.99 million compared to net income of USD 8.02 million a year ago.

Basic loss per share from continuing operations was USD 0.77.